Cherry E, Slater M, Salomon H, Rud E, Wainberg M A
McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, Canada.
Antimicrob Agents Chemother. 1997 Dec;41(12):2763-5. doi: 10.1128/AAC.41.12.2763.
Variants of simian immunodeficiency virus (SIV) that display greater than 2,000-fold resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine (3TC) were generated through in vitro passage and drug selection. The polymerase regions of several of these resistant viruses were sequenced and were found to share either of two codon alterations at site 184 in reverse transcriptase (ATG to ATA [methionine to isoleucine] and ATG to GTA [methionine to valine]). The biological relevance of these substitutions for 3TC was confirmed by site-directed mutagenesis with the SIVmac239 infectious recombinant clone of SIV.
通过体外传代和药物筛选,产生了对2',3'-二脱氧-3'-硫代胞苷(3TC)的(-)对映体具有超过2000倍抗性的猿猴免疫缺陷病毒(SIV)变体。对其中几种抗性病毒的聚合酶区域进行了测序,发现它们在逆转录酶的第184位共享两种密码子改变之一(ATG变为ATA [甲硫氨酸变为异亮氨酸]和ATG变为GTA [甲硫氨酸变为缬氨酸])。通过使用SIV的SIVmac239感染性重组克隆进行定点诱变,证实了这些取代对3TC的生物学相关性。